# Reliance Life Sciences Private Limited – FDA Inspection, Feb 22, 2019

Source: https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/f95a3d58-e9f3-4080-8e57-56a6cf432d59
Source feed: FDA_Inspections

> FDA inspection 1081821 of Reliance Life Sciences Private Limited, February 22, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 310. Form 483 issued. 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1081821
- Company Name: Reliance Life Sciences Private Limited
- Inspection Date: 2019-02-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 1

## Related Documents

- [FDA Inspection 1311632 - 2026-02-27](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/ccab4917-175f-46db-ad0c-ba158ab3159d)
- [FDA Inspection 1170339 - 2022-04-15](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/25bd4384-4ea7-4998-8065-2fb38edb15d1)
- FDA Inspection 1113122 - 2019-11-22
- [FDA Inspection 1070144 - 2018-10-16](https://www.keypedia.com/records/fda_inspections/reliance-life-sciences-private-limited/f81e0521-c3a6-4bcf-9fb0-651407a13902)
- FDA Inspection 1047623 - 2018-01-25

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/tiara-n-brown-crosen/8255649d-25a9-49fa-a28d-0cdda922c0c3)

Company: https://www.keypedia.com/companies/reliance-life-sciences-private-limited/14b16d70-e482-4647-a231-4eb4a1aab98f

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8